NORTHWEST BIOTHERAPEUTICS INC Write off of Deferred Debt Issuance Cost
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Write off of Deferred Debt Issuance Cost of $400.00 thousand for the 0-month period ending 2018-12-14, per its 10-K filed 2019-04-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2019-04-02
- NORTHWEST BIOTHERAPEUTICS INC write off of deferred debt issuance cost for the quarter ending 2015-12-31 was $0.00.
- NORTHWEST BIOTHERAPEUTICS INC write off of deferred debt issuance cost for the quarter ending 2015-09-30 was $68.00K.
- NORTHWEST BIOTHERAPEUTICS INC write off of deferred debt issuance cost for the quarter ending 2015-06-30 was $234.00K.
- NORTHWEST BIOTHERAPEUTICS INC write off of deferred debt issuance cost for the quarter ending 2015-03-31 was $0.00.
- NORTHWEST BIOTHERAPEUTICS INC write off of deferred debt issuance cost for fiscal 2015 was $302.00K.
- NORTHWEST BIOTHERAPEUTICS INC write off of deferred debt issuance cost for fiscal 2014 was $0.00.
| Period end | Write off of Deferred Debt Issuance Cost 0 month | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 6 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|---|---|---|---|
| 2018-12-14 | $400.00K 10-K · filed 2019-04-02 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $68.00K derived: sum of 2 quarters · filed 2016-03-16 | $302.00K derived: sum of 3 quarters · filed 2016-03-16 | $302.00K 10-K · filed 2016-03-16 | |
| 2015-09-30 | $68.00K 10-Q · filed 2015-11-09 | $302.00K derived: sum of 2 quarters · filed 2015-11-09 | $302.00K 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | $234.00K 10-Q · filed 2015-08-10 | $234.00K 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2016-03-16 | ||||
| 2014-12-31 | $0.00 10-K · filed 2016-03-16 |